We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
-3.33%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$9.4B
AUM Growth
-$1.47B
(-14%)
Cap. Flow
-$936M
Cap. Flow
% of AUM
-9.97%
Top 10 Holdings %
Top 10 Hldgs %
27.51%
Holding
1,295
New
171
Increased
621
Reduced
344
Closed
156
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$109M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$60M |
| 3 |
Qualcomm
QCOM
|
+$51.7M |
| 4 |
Texas Instruments
TXN
|
+$40M |
| 5 |
Microsoft
MSFT
|
+$37.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.72B |
| 2 |
Intel
INTC
|
+$70.3M |
| 3 |
KraneShares CSI China Internet ETF
KWEB
|
+$60.1M |
| 4 |
iShares China Large-Cap ETF
FXI
|
+$43.5M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.79% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 10.38% |
| 4 | Energy | 7.34% |
| 5 | Consumer Discretionary | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDCE
226
DELISTED
PDC Energy, Inc.
PDCE
| $6.94M | 0.07% |
120,122
-27,505
| -19% | -$1.69M |
|
|
BHVN
227
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $6.94M | 0.07% |
45,902
+19,423
| +73% | +$2.88M |
|
228
Neurocrine Biosciences
NBIX
$16.8B
| $6.92M | 0.07% |
65,129
+24,727
| +61% | +$2.51M |
|
229
Hartford Financial Services
HIG
$38.9B
| $6.87M | 0.07% |
110,980
+6,715
| +6% | +$437K |
|
230
Align Technology
ALGN
$12.1B
| $6.83M | 0.07% |
32,953
+1,853
| +6% | +$477K |
|
|
CIVI
231
DELISTED
Civitas Resources
CIVI
| $6.82M | 0.07% |
118,861
-35,118
| -23% | -$2.07M |
|
|
PR
232
Permian Resources
PR
$17.8B
| $6.79M | 0.07% |
999,087
-343,592
| -26% | -$2.37M |
|
233
CRISPR Therapeutics
CRSP
$4.73B
| $6.76M | 0.07% |
103,446
+43,569
| +73% | +$3.16M |
|
234
Sarepta Therapeutics
SRPT
$1.57B
| $6.72M | 0.07% |
60,831
+504
| +0.8% | +$50.8K |
|
235
Ionis Pharmaceuticals
IONS
$8.6B
| $6.72M | 0.07% |
151,974
+32,691
| +27% | +$1.38M |
|
|
VTLE
236
DELISTED
Vital Energy
VTLE
| $6.71M | 0.07% |
106,711
-3,963
| -4% | -$282K |
|
237
CVS Health
CVS
$133B
| $6.7M | 0.07% |
70,200
+38,384
| +121% | +$3.8M |
|
|
ISEE
238
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $6.69M | 0.07% |
372,762
+22,146
| +6% | +$291K |
|
239
EQT Corp
EQT
$33.3B
| $6.69M | 0.07% |
164,068
-94,891
| -37% | -$4.12M |
|
240
Matador Resources
MTDR
$6.2B
| $6.65M | 0.07% |
136,023
-54,376
| -29% | -$2.93M |
|
241
Northrop Grumman
NOC
$77.1B
| $6.62M | 0.07% |
14,085
+2,407
| +21% | +$1.15M |
|
242
Halozyme
HALO
$9.79B
| $6.62M | 0.07% |
167,295
+80,143
| +92% | +$3.54M |
|
243
Nasdaq
NDAQ
$52.7B
| $6.6M | 0.07% |
116,409
+7,200
| +7% | +$423K |
|
244
Alnylam Pharmaceuticals
ALNY
$27.5B
| $6.58M | 0.07% |
32,892
+1,702
| +5% | +$325K |
|
245
NVR
NVR
$16.5B
| $6.58M | 0.07% |
1,650
-32
| -2% | -$136K |
|
|
CPE
246
DELISTED
Callon Petroleum Company
CPE
| $6.57M | 0.07% |
187,716
-19,521
| -9% | -$780K |
|
247
Ironwood Pharmaceuticals
IRWD
$696M
| $6.53M | 0.07% |
629,974
+304,990
| +94% | +$3.46M |
|
248
Acadia Pharmaceuticals
ACAD
$4.43B
| $6.52M | 0.07% |
398,676
+175,222
| +78% | +$2.84M |
|
249
United Therapeutics
UTHR
$25.8B
| $6.5M | 0.07% |
31,054
+13,707
| +79% | +$3.06M |
|
250
SM Energy
SM
$7.8B
| $6.49M | 0.07% |
172,677
-72,967
| -30% | -$2.87M |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q3 2022 Portfolio in Review
As of Q3 2022, Rafferty Asset Management held 1,295 positions worth $9.4B, down 14% from $10.9B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Rafferty Asset Management withdrew a net $936M in Q3 2022, closing 156 positions and reducing 344 holdings. Its most notable exit was iShares Russell 1000 Value ETF, an estimated $21.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Rafferty Asset Management opened a new position in American Express worth $28M.
- Rafferty Asset Management's largest Q3 2022 buy was American Express: 207,400 shares worth $28M.
- Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q3 2022, an estimated $109M increase.
- Rafferty Asset Management's biggest Q3 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.72B.
- Rafferty Asset Management fully exited iShares Russell 1000 Value ETF in Q3 2022, selling an estimated $21.8M.
- Rafferty Asset Management's ten largest holdings make up 28% of its $9.4B portfolio in Q3 2022.
- Rafferty Asset Management opened 171 new positions and closed 156 in Q3 2022.
- Rafferty Asset Management's portfolio value fell 14% quarter-over-quarter to $9.4B.
Based on Rafferty Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.